-
-
-
-
-
-
-
FDA accepts Takeda drug application for narcolepsy treatment
-
-
-
-
-
-
-
Truist Securities Comments on Centessa Pharmaceuticals (CNTA) Amid 18pct Drop
-
-
-
-
-
-
-
Takeda receives FDA clearance for HYQVIA administration devices
-
-
-
-
-
-
-
Keros Therapeutics (KROS) Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept
-
-
-
-
-
-
-
Takeda (TAK) Reports Phase 3 Topline Results for Soticlestat
-
412,810 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

